CXCL14 Antibody (C-term) Blocking Peptide
€363.00
In stock
SKU
AC-BP8815b
Background:
Potent chemoattractant for neutrophils, and weaker for dendritic cells. Not chemotactive for T-cells, B-cells, monocytes, natural killer cells or granulocytes. It does not inhibit proliferation of myeloid progenitors in colony formation assays.
Other Names:
C-X-C motif chemokine 14, Chemokine BRAK, MIP-2G, Small-inducible cytokine B14, CXCL14, MIP2G, NJAC, SCYB14
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8815b was selected from the C-term region of human CXCL14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CXCL14
Gene ID: 9547
Primary Accession: O95715
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
Potent chemoattractant for neutrophils, and weaker for dendritic cells. Not chemotactive for T-cells, B-cells, monocytes, natural killer cells or granulocytes. It does not inhibit proliferation of myeloid progenitors in colony formation assays.
Other Names:
C-X-C motif chemokine 14, Chemokine BRAK, MIP-2G, Small-inducible cytokine B14, CXCL14, MIP2G, NJAC, SCYB14
Target/Specificity:
The synthetic peptide sequence used to generate the antibody AP8815b was selected from the C-term region of human CXCL14. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.
Gene Name: CXCL14
Gene ID: 9547
Primary Accession: O95715
Format: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
| Is Featured? | No |
|---|
Write Your Own Review